CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Recruiting N/A Interventional Study
Ureteropelvic Junction Obstruction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
4 Weeks – 8 Weeks
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
75 (estimated)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Infants: * Aged of 4 to 8 weeks of life * Presenting an ureteropelvic junction obstruction (UPJO) detected before birth by ultrasound * Presenting an UPJO, defined by an Antero-Posterior Renal Pelvic Diameter greater or equal to 15 mm, confirmed by ultrasound post-natally betwe…
Contacts

Lucie Auzanneau

0262359949

lucie.auzanneau@chu-reunion.fr

CONTACT

Valérie Fontaine

promotion.drci@chu-reunion.fr

CONTACT